Semiquantitative analysis of human papillomavirus DNA in cervical intraepithelial neoplasia by a differential polymerase chain reaction.

A differential polymerase chain reaction (PCR), which takes account of both the human papillomavirus (HPV) type and the amount of viral DNA, was applied to 100 cervical intraepithelial neoplasias (CIN) in order to improve the characterisation of the lesions. One hundred women with cytological smears suggestive of CIN I-III and a colposcopically guided punch biopsy were studied. DNA was phenol-extracted and a consensus PCR with L1 primers and a type-specific PCR for HPV-16 and-18 E6 were performed in parallel. The different sensitivity of the PCR methods allowed a semiquantitative analysis of viral DNA. HPV analysis was possible in all 100 very small cervical punch biopsies. Of the lesions 79% were HPVpositive. The percentage of HPV-16-positive lesions increased significantly (P < 0.001) with the degree of severity of CIN (CIN I: 46%, CIN II: 63%, CIN III: 85%). The percentage of CIN with a high viral load increased also with the grade of CIN (CIN I: 8%, CIN II: 33%, CIN III: 44%). Cytologically positive lesions (Pap IIID or IVa) had significantly more frequently (p < 0.02) a high viral load: 39% vs. 10% of cytologically false negative lesions. In conclusion, type-specific PCR had a very high sensitivity in the detection of HPV-DNA also in cytologically false negative CIN. The addition of the less sensitive consensusPCR allowed a semiquantitative analysis of the viral copy number. The higher amount of viral DNA in cytologically positive lesions, which may correspond to a higher rate of proliferation, reflects a possible role of the viral load in the progression of CIN. In clinical practice, differential HPVPCR could help to improve the management of CIN.

[1]  H. Hausen,et al.  Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. , 1994, Current topics in microbiology and immunology.

[2]  F. Guijon,et al.  Quantification of HPV‐16 E6‐E7 transcription in cervical intraepithelial neoplasia by reverse transcriptase polymerase chain reaction , 1993, International journal of cancer.

[3]  P. Griffiths,et al.  Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report. , 1993, British Journal of Cancer.

[4]  K. Holmes,et al.  A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection , 1992, The New England journal of medicine.

[5]  J. Cuzick,et al.  Human papillomavirus type 16 DNA in cervical smears as predictor of high-grade cervical cancer , 1992, The Lancet.

[6]  R Reid,et al.  Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. , 1992, Obstetrics and gynecology.

[7]  Gravitt Pe,et al.  Polymerase chain reaction-based methods for the detection of human papillomavirus DNA. , 1992, IARC scientific publications.

[8]  Schiffman Mh Validation of hybridization assays: correlation of filter in situ, dot blot and PCR with Southern blot. , 1992 .

[9]  S. Vermund,et al.  Human papillomavirus infection and other risk factors for cervical neoplasia: A case‐control study , 1991, International journal of cancer.

[10]  J. Walboomers,et al.  Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia , 1991, International journal of cancer.

[11]  J. Walboomers,et al.  General primer‐mediated polymerase chain reaction permits the detection of sequenced and still unsequenced human papillomavirus genotypes in cervical scrapes and carcinomas , 1990, International journal of cancer.

[12]  P. McNicol,et al.  Detection of human papillomavirus DNA in prostate gland tissue by using the polymerase chain reaction amplification assay , 1990, Journal of clinical microbiology.

[13]  L. Brinton,et al.  Human papillomavirus infection and cervical cancer in Latin America. , 1989, The New England journal of medicine.

[14]  C. Woodman,et al.  The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection. , 1989, BMJ.

[15]  K. Mullis,et al.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. , 1985, Science.

[16]  L. Gissmann,et al.  A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[17]  D. Cox Regression Models and Life-Tables , 1972 .